1	Vimentin	_	NN	_	_	2	VMOD	_	_
2	is	_	VBZ	_	_	0	ROOT	_	_
3	preferentially	_	RB	_	_	2	VMOD	_	_
4	expressed	_	VBN	_	_	2	VC	_	_
5	in	_	IN	_	_	4	VMOD	_	_
6	human	_	JJ	_	_	8	NMOD	_	_
7	breast	_	NN	_	_	8	NMOD	_	_
8	carcinomas	_	NNS	_	_	5	PMOD	_	_
9	with	_	IN	_	_	8	NMOD	_	_
10	low	_	JJ	_	_	12	NMOD	_	_
11	estrogen	_	NN	_	_	12	NMOD	_	_
12	receptor	_	NN	_	_	9	PMOD	_	_
13	and	_	CC	_	_	12	COORD	_	_
14	high	_	JJ	_	_	17	NMOD	_	_
15	Ki-67	_	NN	_	_	17	NMOD	_	_
16	growth	_	NN	_	_	17	NMOD	_	_
17	fraction	_	NN	_	_	13	CONJ	_	_
18	.	_	.	_	_	2	P	_	_
		
1	Vimentin	_	NN	_	_	2	NMOD	_	_
2	expression	_	NN	_	_	17	VMOD	_	_
3	,	_	,	_	_	2	P	_	_
4	growth	_	NN	_	_	5	NMOD	_	_
5	fractions	_	NNS	_	_	2	COORD	_	_
6	(	_	(	_	_	7	P	_	_
7	GF	_	NN	_	_	5	PRN	_	_
8	)	_	)	_	_	7	P	_	_
9	,	_	,	_	_	5	P	_	_
10	and	_	CC	_	_	5	COORD	_	_
11	estrogen	_	NN	_	_	12	NMOD	_	_
12	receptor	_	NN	_	_	16	NMOD	_	_
13	(	_	(	_	_	14	P	_	_
14	ER	_	NN	_	_	12	PRN	_	_
15	)	_	)	_	_	14	P	_	_
16	levels	_	NNS	_	_	10	CONJ	_	_
17	were	_	VBD	_	_	0	ROOT	_	_
18	determined	_	VBN	_	_	17	VC	_	_
19	for	_	IN	_	_	18	VMOD	_	_
20	90	_	CD	_	_	24	NMOD	_	_
21	untreated	_	JJ	_	_	24	NMOD	_	_
22	primary	_	JJ	_	_	24	NMOD	_	_
23	breast	_	NN	_	_	24	NMOD	_	_
24	carcinomas	_	NNS	_	_	19	PMOD	_	_
25	.	_	.	_	_	17	P	_	_
		
1	Coexpression	_	NN	_	_	6	VMOD	_	_
2	of	_	IN	_	_	1	NMOD	_	_
3	keratin	_	NN	_	_	2	PMOD	_	_
4	and	_	CC	_	_	3	COORD	_	_
5	vimentin	_	NN	_	_	4	CONJ	_	_
6	was	_	VBD	_	_	0	ROOT	_	_
7	found	_	VBN	_	_	6	VC	_	_
8	in	_	IN	_	_	7	VMOD	_	_
9	approximately	_	RB	_	_	11	NMOD	_	_
10	20	_	CD	_	_	9	DEP	_	_
11	%	_	NN	_	_	8	PMOD	_	_
12	of	_	IN	_	_	11	NMOD	_	_
13	the	_	DT	_	_	14	NMOD	_	_
14	tumors	_	NNS	_	_	12	PMOD	_	_
15	regardless	_	RB	_	_	16	PMOD	_	_
16	of	_	IN	_	_	14	NMOD	_	_
17	menopausal	_	JJ	_	_	18	NMOD	_	_
18	status	_	NN	_	_	16	PMOD	_	_
19	.	_	.	_	_	6	P	_	_
		
1	Vimentin	_	NN	_	_	2	VMOD	_	_
2	was	_	VBD	_	_	0	ROOT	_	_
3	expressed	_	VBN	_	_	2	VC	_	_
4	preferentially	_	RB	_	_	3	VMOD	_	_
5	in	_	IN	_	_	3	VMOD	_	_
6	tumor	_	NN	_	_	7	NMOD	_	_
7	cells	_	NNS	_	_	5	PMOD	_	_
8	of	_	IN	_	_	7	NMOD	_	_
9	high-grade	_	JJ	_	_	12	NMOD	_	_
10	ductal	_	JJ	_	_	12	NMOD	_	_
11	breast	_	NN	_	_	12	NMOD	_	_
12	carcinomas	_	NNS	_	_	8	PMOD	_	_
13	(	_	(	_	_	18	P	_	_
14	15	_	CD	_	_	16	DEP	_	_
15	of	_	IN	_	_	16	DEP	_	_
16	28	_	CD	_	_	18	NMOD	_	_
17	histologic	_	JJ	_	_	18	NMOD	_	_
18	grade	_	NN	_	_	12	PRN	_	_
19	3	_	CD	_	_	24	NMOD	_	_
20	vs.	_	CC	_	_	19	COORD	_	_
21	0	_	CD	_	_	20	CONJ	_	_
22	of	_	IN	_	_	21	COORD	_	_
23	40	_	CD	_	_	22	COORD	_	_
24	grades	_	NNS	_	_	18	APPO	_	_
25	1	_	CD	_	_	24	NMOD	_	_
26	and	_	CC	_	_	25	COORD	_	_
27	2	_	CD	_	_	26	CONJ	_	_
28	)	_	)	_	_	18	P	_	_
29	.	_	.	_	_	2	P	_	_
		
1	Vimentin	_	NN	_	_	2	NMOD	_	_
2	expression	_	NN	_	_	3	VMOD	_	_
3	was	_	VBD	_	_	0	ROOT	_	_
4	found	_	VBN	_	_	3	VC	_	_
5	preferentially	_	RB	_	_	4	VMOD	_	_
6	in	_	IN	_	_	4	VMOD	_	_
7	tumors	_	NNS	_	_	6	PMOD	_	_
8	with	_	IN	_	_	7	NMOD	_	_
9	high	_	JJ	_	_	10	NMOD	_	_
10	GF	_	NN	_	_	8	PMOD	_	_
11	(	_	(	_	_	16	P	_	_
12	greater	_	JJR	_	_	14	DEP	_	_
13	than	_	IN	_	_	14	DEP	_	_
14	15	_	CD	_	_	16	NMOD	_	_
15	%	_	NN	_	_	14	AMOD	_	_
16	Ki-67	_	NN	_	_	10	PRN	_	_
17	positive	_	JJ	_	_	16	APPO	_	_
18	by	_	IN	_	_	17	AMOD	_	_
19	immunoperoxidase	_	NN	_	_	20	NMOD	_	_
20	staining	_	NN	_	_	18	PMOD	_	_
21	)	_	)	_	_	16	P	_	_
22	and	_	CC	_	_	10	COORD	_	_
23	low	_	JJ	_	_	25	NMOD	_	_
24	ER	_	NN	_	_	25	NMOD	_	_
25	levels	_	NNS	_	_	22	CONJ	_	_
26	(	_	(	_	_	31	P	_	_
27	less	_	JJR	_	_	29	DEP	_	_
28	than	_	IN	_	_	29	DEP	_	_
29	60	_	CD	_	_	31	NMOD	_	_
30	fmols/mg	_	NN	_	_	31	NMOD	_	_
31	protein	_	NN	_	_	25	PRN	_	_
32	by	_	IN	_	_	31	NMOD	_	_
33	a	_	DT	_	_	36	NMOD	_	_
34	monoclonal	_	JJ	_	_	36	NMOD	_	_
35	enzyme	_	NN	_	_	36	NMOD	_	_
36	immunoassay	_	NN	_	_	32	PMOD	_	_
37	)	_	)	_	_	31	P	_	_
38	.	_	.	_	_	3	P	_	_
		
1	Sixty-eight	_	CD	_	_	2	NMOD	_	_
2	percent	_	NN	_	_	8	VMOD	_	_
3	of	_	IN	_	_	2	NMOD	_	_
4	tumors	_	NNS	_	_	3	PMOD	_	_
5	in	_	IN	_	_	4	NMOD	_	_
6	this	_	DT	_	_	7	NMOD	_	_
7	group	_	NN	_	_	5	PMOD	_	_
8	were	_	VBD	_	_	0	ROOT	_	_
9	vimentin	_	NN	_	_	8	VMOD	_	_
10	positive	_	JJ	_	_	9	AMOD	_	_
11	and	_	CC	_	_	8	COORD	_	_
12	88	_	CD	_	_	13	NMOD	_	_
13	%	_	NN	_	_	18	VMOD	_	_
14	of	_	IN	_	_	13	NMOD	_	_
15	all	_	DT	_	_	17	NMOD	_	_
16	vimentin-positive	_	JJ	_	_	17	NMOD	_	_
17	tumors	_	NNS	_	_	14	PMOD	_	_
18	fell	_	VBP	_	_	11	CONJ	_	_
19	into	_	IN	_	_	18	VMOD	_	_
20	this	_	DT	_	_	21	NMOD	_	_
21	category	_	NN	_	_	19	PMOD	_	_
22	.	_	.	_	_	8	P	_	_
		
1	More	_	JJR	_	_	3	DEP	_	_
2	than	_	IN	_	_	3	DEP	_	_
3	50	_	CD	_	_	4	NMOD	_	_
4	%	_	NN	_	_	9	VMOD	_	_
5	of	_	IN	_	_	4	NMOD	_	_
6	the	_	DT	_	_	8	NMOD	_	_
7	tumor	_	NN	_	_	8	NMOD	_	_
8	cells	_	NNS	_	_	5	PMOD	_	_
9	coexpressed	_	VBD	_	_	0	ROOT	_	_
10	vimentin	_	NN	_	_	9	VMOD	_	_
11	and	_	CC	_	_	10	COORD	_	_
12	keratin	_	NN	_	_	11	CONJ	_	_
13	.	_	.	_	_	9	P	_	_
		
1	Thus	_	RB	_	_	5	VMOD	_	_
2	,	_	,	_	_	5	P	_	_
3	vimentin	_	NN	_	_	4	NMOD	_	_
4	expression	_	NN	_	_	5	VMOD	_	_
5	may	_	MD	_	_	0	ROOT	_	_
6	be	_	VB	_	_	5	VC	_	_
7	helpful	_	JJ	_	_	6	VMOD	_	_
8	in	_	IN	_	_	7	AMOD	_	_
9	identifying	_	VBG	_	_	8	PMOD	_	_
10	a	_	DT	_	_	12	NMOD	_	_
11	substantial	_	JJ	_	_	12	NMOD	_	_
12	subset	_	NN	_	_	9	VMOD	_	_
13	of	_	IN	_	_	12	NMOD	_	_
14	ER-independent	_	JJ	_	_	16	NMOD	_	_
15	breast	_	NN	_	_	16	NMOD	_	_
16	carcinomas	_	NNS	_	_	13	PMOD	_	_
17	with	_	IN	_	_	16	NMOD	_	_
18	poor	_	JJ	_	_	20	NMOD	_	_
19	prognostic	_	JJ	_	_	20	NMOD	_	_
20	indicators	_	NNS	_	_	17	PMOD	_	_
21	.	_	.	_	_	5	P	_	_
		
